<div class="tables frame-topbot rowsep-0 colsep-0" id="tbl2">
<div class="captions"><span id="cecap70"><p id="spara130"><span class="label">Table 2</span>. Outcomes at 7 years in patients stratified by baseline polyvascular disease and type 2 diabetes</p></span></div>
<div class="groups"><table>
<thead>
<tr class="valign-top">
<th scope="col"></th>
<th scope="col" class="align-left rowsep-1" colspan="4">
<strong>Polyvascular disease</strong><a name="btbl2fn1" href="#tbl2fn1" class="workspace-trigger"><sup>*</sup></a> <strong>status</strong>
</th>
<th scope="col" class="align-left rowsep-1" colspan="4">
<strong>Polyvascular disease</strong><a name="btbl2fn1" href="#tbl2fn1" class="workspace-trigger"><sup>*</sup></a> <strong>and type 2 diabetes status</strong>
</th>
</tr>
<tr class="valign-top rowsep-1">
<th scope="col"></th>
<th scope="col" class="align-left">Polyvascular disease (n=1930)</th>
<th scope="col" class="align-left">No polyvascular disease (n=16 204)</th>
<th scope="col" class="align-left">Adjusted hazard ratio (95% CI)<a name="btbl2fn2" href="#tbl2fn2" class="workspace-trigger"><sup>†</sup></a>
</th>
<th scope="col" class="align-left">p value</th>
<th scope="col" class="align-left">Polyvascular disease and type 2 diabetes (n=737)</th>
<th scope="col" class="align-left">Polyvascular disease and no type 2 diabetes (n=1193)</th>
<th scope="col" class="align-left">Adjusted hazard ratio (95% CI)<a name="btbl2fn2" href="#tbl2fn2" class="workspace-trigger"><sup>†</sup></a>
</th>
<th scope="col" class="align-left">p value</th>
</tr>
</thead>
<tbody>
<tr class="valign-top">
<td class="align-left">Primary composite endpoint<a name="btbl2fn3" href="#tbl2fn3" class="workspace-trigger"><sup>‡</sup></a>
</td>
<td class="align-left">768 (47·3%)</td>
<td class="align-left">4544 (32·2%)</td>
<td class="align-left">1·28 (1·18–1·38)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">363 (60·0%)</td>
<td class="align-left">405 (39·8%)</td>
<td class="align-left">1·60 (1·38–1·85)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Cardiovascular death, myocardial infarction, or stroke</td>
<td class="align-left">593 (37·8%)</td>
<td class="align-left">2653 (19·5%)</td>
<td class="align-left">1·55 (1·41–1·70)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">294 (50·5%)</td>
<td class="align-left">299 (30·3%)</td>
<td class="align-left">1·73 (1·46–2·04)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Cardiovascular death</td>
<td class="align-left">240 (15·4%)</td>
<td class="align-left">834 (5·9%)</td>
<td class="align-left">1·53 (1·32–1·78)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">126 (21·2%)</td>
<td class="align-left">114 (12·0%)</td>
<td class="align-left">1·87 (1·44–2·43)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Myocardial infarction</td>
<td class="align-left">344 (23·1%)</td>
<td class="align-left">1750 (13·0%)</td>
<td class="align-left">1·40 (1·24–1·58)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">181 (33·6%)</td>
<td class="align-left">163 (17·1%)</td>
<td class="align-left">1·81 (1·46–2·25)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Coronary revascularisation<a name="btbl2fn4" href="#tbl2fn4" class="workspace-trigger"><sup>§</sup></a>
</td>
<td class="align-left">392 (25·3%)</td>
<td class="align-left">3090 (22·3%)</td>
<td class="align-left">1·05 (0·94–1·16)</td>
<td class="align-left">0·4192</td>
<td class="align-left">185 (33·4%)</td>
<td class="align-left">207 (20·7%)</td>
<td class="align-left">1·57 (1·28–1·93)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Stroke</td>
<td class="align-left">154 (10·9%)</td>
<td class="align-left">487 (3·8%)</td>
<td class="align-left">2·22 (1·84–2·68)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">68 (13·1%)</td>
<td class="align-left">86 (9·7%)</td>
<td class="align-left">1·41 (1·02–1·95)</td>
<td class="align-left">0·0384</td>
</tr>
<tr class="valign-top">
<td class="align-left">Congestive heart failure<a name="btbl2fn4" href="#tbl2fn4" class="workspace-trigger"><sup>§</sup></a>
</td>
<td class="align-left">158 (11·1%)</td>
<td class="align-left">551 (4·2%)</td>
<td class="align-left">1·49 (1·24–1·79)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">80 (15·0%)</td>
<td class="align-left">78 (8·9%)</td>
<td class="align-left">1·70 (1·23–2·34)</td>
<td class="align-left">0·0012</td>
</tr>
<tr class="valign-top">
<td class="align-left">Cardiovascular hospitalisation<a name="btbl2fn4" href="#tbl2fn4" class="workspace-trigger"><sup>§</sup></a>
</td>
<td class="align-left">1024 (63·3%)</td>
<td class="align-left">6097 (43·4%)</td>
<td class="align-left">1·37 (1·28–1·47)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">437 (72·3%)</td>
<td class="align-left">587 (58·1%)</td>
<td class="align-left">1·37 (1·20–1·55)</td>
<td class="align-left">&lt;0·0001</td>
</tr>
<tr class="valign-top">
<td class="align-left">Peripheral revascularisation</td>
<td class="align-left">121 (8·4%)</td>
<td class="align-left">200 (1·5%)</td>
<td class="align-left">4·77 (3·75–6·06)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">49 (8·7%)</td>
<td class="align-left">72 (8·1%)</td>
<td class="align-left">1·11 (0·76–1·61)</td>
<td class="align-left">0·5985</td>
</tr>
<tr class="valign-top">
<td class="align-left">Amputation</td>
<td class="align-left">13 (0·94%)</td>
<td class="align-left">16 (0·12%)</td>
<td class="align-left">5·96 (2·74–12·94)</td>
<td class="align-left">&lt;0·0001</td>
<td class="align-left">8 (1·3%)</td>
<td class="align-left">5 (0·68%)</td>
<td class="align-left">2·85 (0·90–9·08)</td>
<td class="align-left">0·0757</td>
</tr>
</tbody>
</table></div>
<p class="legend"></p>
<p id="spara140">Data are n (Kaplan-Meier %), unless otherwise indicated.</p>
<dl class="footnotes">
<dt id="tbl2fn1">*</dt>
<dd><p id="cenpara20">Polyvascular disease defined as concomitant known peripheral artery disease, stroke or transient ischaemic attack, or both.</p></dd>
<dt id="tbl2fn2">†</dt>
<dd><p id="cenpara30">Adjusted
 for age, sex, previous myocardial infarction, percutaneous coronary 
intervention, coronary artery bypass graft, heart failure, hypertension,
 type 2 diabetes, non-ST-segment elevation myocardial infarction at 
qualifying, and thienopyridine use at enrolment.</p></dd>
<dt id="tbl2fn3">‡</dt>
<dd><p id="cenpara40">Composite
 of cardiovascular death, a major coronary event (ie, a non-fatal 
myocardial infarction, documented unstable angina requiring hospital 
admission, or coronary revascularisation occurring at least 30 days 
after randomisation), or stroke (ischaemic or haemorrhagic).</p></dd>
<dt id="tbl2fn4">§</dt>
<dd><p id="cenpara50">30 days or more after randomisation.</p></dd>
</dl>
</div>
